[go: up one dir, main page]

HU9502832D0 - Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia - Google Patents

Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia

Info

Publication number
HU9502832D0
HU9502832D0 HU9502832A HU9502832A HU9502832D0 HU 9502832 D0 HU9502832 D0 HU 9502832D0 HU 9502832 A HU9502832 A HU 9502832A HU 9502832 A HU9502832 A HU 9502832A HU 9502832 D0 HU9502832 D0 HU 9502832D0
Authority
HU
Hungary
Prior art keywords
iiia
inhibitors
compounds useful
cyclic compounds
glycoprotein iib
Prior art date
Application number
HU9502832A
Other languages
Hungarian (hu)
Other versions
HUT72896A (en
Inventor
William Frank Degrado
Shaker Ahmed Mousa
Anju Parthasarathy
Michael Sworin
Sharon Anne Jackson
Maria Rafalski
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of HU9502832D0 publication Critical patent/HU9502832D0/en
Publication of HUT72896A publication Critical patent/HUT72896A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9502832A 1993-03-29 1994-03-28 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia HUT72896A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3844893A 1993-03-29 1993-03-29

Publications (2)

Publication Number Publication Date
HU9502832D0 true HU9502832D0 (en) 1995-11-28
HUT72896A HUT72896A (en) 1996-06-28

Family

ID=21900014

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9502832A HUT72896A (en) 1993-03-29 1994-03-28 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia

Country Status (10)

Country Link
EP (1) EP0691987A1 (en)
JP (1) JPH08508498A (en)
AU (1) AU6415894A (en)
CA (1) CA2159070A1 (en)
FI (1) FI954556A (en)
HU (1) HUT72896A (en)
NO (1) NO953832L (en)
NZ (1) NZ263456A (en)
PL (1) PL310896A1 (en)
WO (1) WO1994022910A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159072A1 (en) * 1993-03-29 1994-10-13 Lin-Hua Zhang Novel processes and intermediate compounds for the preparation of platelet glycoprotein iib/iiia inhibitors
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
CA2272317C (en) * 1996-11-27 2001-01-30 Rhone-Poulenc Rorer Pharmaceuticals Inc. Pharmaceutical composition comprising a compound having anti-xa activity and a platelet aggregation antagonist compound
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
JP5649825B2 (en) 2007-01-31 2015-01-07 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド Stabilized p53 peptides and methods of use thereof
CA2682174C (en) 2007-03-28 2021-04-06 President And Fellows Of Harvard College Stitched polypeptides
US11673914B2 (en) 2009-11-10 2023-06-13 Allegro Pharmaceuticals, LLC Peptide therapies for reduction of macular thickening
BR112012011731A2 (en) * 2009-11-10 2020-08-25 Allegro Pharmaceuticals, Inc. compositions and methods for inhibiting cell adhesion or targeting diagnostic or therapeutic agents to rgd binding sites
PL2603600T3 (en) 2010-08-13 2019-06-28 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
JP6106159B2 (en) 2011-05-09 2017-03-29 アレグロ ファーマシューティカルズ インコーポレイテッドAllegro Pharmaceuticals,Inc. Pharmaceutical composition comprising RG-cysteic acid peptide
AR088392A1 (en) 2011-10-18 2014-05-28 Aileron Therapeutics Inc PEPTIDOMIMETIC MACROCICLES
CN104144695A (en) 2012-02-15 2014-11-12 爱勒让治疗公司 Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
RU2017145921A (en) 2012-02-15 2019-02-21 Эйлерон Терапьютикс, Инк. PEPTIDOMIMETIC MACROCYCLES
KR20150082307A (en) 2012-11-01 2015-07-15 에일러론 테라퓨틱스 인코포레이티드 Disubstituted amino acids and methods of preparation and use thereof
SG11201702175YA (en) 2014-09-24 2017-04-27 Aileron Therapeutics Inc Peptidomimetic macrocycles and formulations thereof
SG10201902594QA (en) 2014-09-24 2019-04-29 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
KR20170129879A (en) 2015-03-20 2017-11-27 에일러론 테라퓨틱스 인코포레이티드 Peptidomimetic macrocycles and their uses
CN108368161A (en) 2015-09-10 2018-08-03 艾瑞朗医疗公司 Peptidomimetic macrocyclic compound as MCL-1 conditioning agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2636066B1 (en) * 1988-09-02 1991-10-25 Centre Nat Rech Scient CYCLOPEPTIDE DERIVATIVES FOR USE AS SELECTIVE INHIBITORS AGAINST ACTIVE SERINE PROTEASES
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
AU6470590A (en) * 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
IL103252A (en) * 1991-09-30 1997-03-18 Du Pont Merck Pharma CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
FI954556A0 (en) 1995-09-26
FI954556A (en) 1995-09-26
NZ263456A (en) 1996-11-26
EP0691987A1 (en) 1996-01-17
NO953832L (en) 1995-11-28
AU6415894A (en) 1994-10-24
WO1994022910A1 (en) 1994-10-13
JPH08508498A (en) 1996-09-10
PL310896A1 (en) 1996-01-08
NO953832D0 (en) 1995-09-28
CA2159070A1 (en) 1994-10-13
HUT72896A (en) 1996-06-28

Similar Documents

Publication Publication Date Title
HU9502832D0 (en) Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia
AU2025192A (en) Peptide mimetic compounds useful as platelet aggregation inhibitors
AU3143793A (en) Peptide mimetic compounds useful as platelet aggregation inhibitors
AU1400095A (en) Compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
ZA93550B (en) Azabricyclic compounds as calcium channel antagonists
AU3364493A (en) Compounds as calcium channel antagonists
EP0511866A3 (en) Process for the crystallization of cyclic lipopeptides
ITMI932056A1 (en) LOCK FOR CONTAINERS SUCH AS BAGS OR SIMILAR
GB9216384D0 (en) Improvements relating to packaging
GB9317297D0 (en) Biocidal compositions containing organoboron compounds
ZA93549B (en) Azabicyclo compounds as calcium channel antagonists
ZA927515B (en) Cyclic compounds useful as inhibitors of platelet glycoprotein IIb/IIIa
GB9423929D0 (en) Substituted benzene compounds as tranferase inhibitors
AU1398595A (en) Peptide analogs of the factor ixa platelet binding site
GB9209374D0 (en) Improvements relating to sealable containers
WO1994022911A3 (en) A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE
GB2257958B (en) Improvements relating to packaging
GB9302184D0 (en) Improvements relating to the formation of cartosn
GB9222377D0 (en) Improvements relating to packaging containers
GB9205505D0 (en) Cyclic compounds
GB9320958D0 (en) Improvements relating to packaging of articles
GB9214278D0 (en) Improvements relating to packaging
GB2275466B (en) Improvements relating to containers
GB9321861D0 (en) Platelet derived growth factor analogues
GB9324788D0 (en) Improvements relating to packaging

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary prot. due to refusal